E7389
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for E7389, covering 2012-01-30 to 2013-09-30. Get the full timeline:
Most recent: Clinical Trial Update: E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes [Phase 3]